Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-2-8
pubmed:abstractText
A series of phosphonamide-based hydroxamate derivatives were synthesized, and the inhibitory activities were evaluated against various metalloproteinases in order to clarify its selectivity profile. Among the four diastereomeric isomers resulting from the chirality at the C-3 and P atoms, the compound with a (R,R)-configuration both at the C-3 position and the phosphorus atom was found to be potently active, while the other diastereomeric isomers were almost inactive. A number of (R,R)-compounds synthesized here exhibited broad spectrum activities with nanomolar K(i) values against MMP-1, -3, -9, and TACE and also showed nanomolar IC(50) values against HB-EGF shedding in a cell-based inhibition assay. The modeling study using X-ray structure of MMP-3 suggested the possible binding mode of the phosphonamide-based inhibitors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amides, http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 1, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 3, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Metalloendopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/heparin-binding EGF-like growth...
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
919-29
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11831904-Amides, pubmed-meshheading:11831904-Crystallography, X-Ray, pubmed-meshheading:11831904-Epidermal Growth Factor, pubmed-meshheading:11831904-Humans, pubmed-meshheading:11831904-Hydroxamic Acids, pubmed-meshheading:11831904-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:11831904-Matrix Metalloproteinase 1, pubmed-meshheading:11831904-Matrix Metalloproteinase 3, pubmed-meshheading:11831904-Matrix Metalloproteinase 9, pubmed-meshheading:11831904-Metalloendopeptidases, pubmed-meshheading:11831904-Models, Molecular, pubmed-meshheading:11831904-Phosphonic Acids, pubmed-meshheading:11831904-Protease Inhibitors, pubmed-meshheading:11831904-Protein Binding, pubmed-meshheading:11831904-Recombinant Proteins, pubmed-meshheading:11831904-Stereoisomerism, pubmed-meshheading:11831904-Structure-Activity Relationship, pubmed-meshheading:11831904-Tumor Cells, Cultured
pubmed:year
2002
pubmed:articleTitle
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.
pubmed:affiliation
Department of Chemistry, R&D Laboratories, Nippon Organon K.K., 1-5-90, Tomobuchi-cho, Miyakojima-ku, Osaka 534-0016, Japan. masaaki-sawa@dainippon-pharm.co.jp
pubmed:publicationType
Journal Article